Correlation of adiponectin levels with disease activity score in rheumatoid arthritis patients
Keywords:
adiponectin, disease activity score, rheumatoid arthritisAbstract
Introduction: Rheumatoid arthritis is the most common chronic inflammatory joint disease of unknown etiology that primarily affects the joints and is marked by symmetric, peripheral poly arthritis. To estimation of adiponectin can be useful for early diagnosis and progression of rheumatoid arthritis. Materials and Methods: Total 90 subjects included in the present study were 60 patients were diagnosed with Rheumatoid arthritis and 30 age, gender and BMI matched healthy subjects were included as controls. biochemical, disease activity score and serum adiponectin levels were measured from all the subjects. Relevant statistical analysis was done by using SPSS and Microsoft Excel Spread Sheets. Results: Fasting blood sugars, post parandial blood sugars and triglycerides when compared to controls (P=0.0001**). Serum adiponectin concentration was found to be significantly increased in RA patients compared to healthy controls (p<0.0001). There was a significantly positive correlation between serum adiponectin and disease activity score. Conclusion: This study concludes significantly elevated levels of serum adiponectin might be used for early diagnosis and progression of rheumatoid arthritis.
Downloads
References
Aletaha D, Funovits J, Neogi T, Felson DT, Silman AJ, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569-2581.
Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7:R796-R806.
Alkady EA, Ahmed HM, Tag L, Abdou MA. Serum and synovial adiponectin, resistin and visfatin levels in rheumatoid arthritis patients. Relation to disease activity. Z Rheumatol. 2011;78:602-8.
Arnett FC, Edworthy SM, Bloch DA, Mc Shane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
Cao H, Lin J, Chen W, Xu G, Sun C. Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: A meta-analysis and systematic review. Autoimmunity. 2016;49:547-53.
El-Hini SH, Mohamed FI, Hassan AA, Fatma A, Mahmoud A, Ibraheem HM. Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients. Rheumatol Int. 2013;33:2283-9.
Gonzalez-Gay MA1, Llorca J, Garcia-Unzueta MT, Gonzalez-Juanatey C, De Matias JM, Martin J. High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol. 2008 Jul-Aug;26(4):596-603.
Handa R, Rao UR, Lewis JF, Rambhad G, Shiff S, Ghia CJ. Literature review of rheumatoid arthritis in India. Int J Rheum Dis. 2016;19:440-51.
Lahita RG. Sex hormones and the immune system-Part 1. Human data. Baillieres Clin Rheumatol 1990;4:1-12.
Lee YH, Bae SC. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis. Int J Rheum Dis. 2017. [Epub ahead of print].
Li P, Yang L, Ma CL, Liu B, Zhang X, Ding R, et al. Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms. Clin Rheumatol. 2015;34:1025-30.
Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62:1576–1582.
Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T et al. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol. 2008 ;35:936–8.
Nielung L, Christensen R, Danneskiold-Samsøe B, Bliddal H, Holm CC, Ellegaard K, Slott Jensen H, Bartels EM. Validity and Agreement between the 28-Joint Disease Activity Score Based on C-Reactive Protein and Erythrocyte Sedimentation Rate in Patients with Rheumatoid Arthritis. Arthritis. 2015;2015:401690.
Ozgen M, Koca SS, Dagli N, Bolin M, Ustundag B, Isik A. serum adiponectin and vaspin levels in rheumatoid arthritis. Arch Med Res. 2010;41:457-63.
Peter E. Lipsky. Rheumatoid arthritis. In: Anthony S Fauci, Braunwald E, Dennis L Kasper et al, editors. Harrison's Principles of Internal Medicine.17th Edition. USA: Mc Graw- Hill companies, Inc; 2008.2083-86, 2074-78.
Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981;24:1308-15.
Popa C, Netea MG, Graaf JD, Hoogen FHJV, Radstake TRDJ, Toenhake-dijkstra H, et al. Circulating adiponectin concentrations during tumor necrosis factor blocked in patients with active rheumatoid arthritis. J Rheumatol. 2009;36:724-30.
Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094-108.
Sharma JN, Arora RB. Arthritis in ancient Indian literature. Indian J Hist Sci. 1973;8:37-42.
Sharma JN. Cardiovascular system and its diseases in ancient Indian literature. Indian J Chest Dis. 1967;9:32-40.
Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4(suppl 3):S265-S272.
Smolen JS, B reedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42:244-57.
Targonska-Stepniak B, Dryglewska M, Majdan M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int. 2010;30:731-7.
Turesson C, McClelland RL, Christianson TJH, Matteson EL. Severe extra‐articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2007; 66:70–75.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
